Actively Recruiting
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Led by Johns Hopkins University · Updated on 2026-03-27
500
Participants Needed
1
Research Sites
207 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
N
National Eye Institute (NEI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the autonomous AI system in detecting diabetic retinopathy from retinal images of youth with diabetes.
CONDITIONS
Official Title
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meets American Diabetes Association criteria for diabetic retinopathy screening
- Diagnosis of Type 1 diabetes for 3 or more years and age 11 or in puberty
- Diagnosis of Type 2 diabetes
- Patients aged 8 to 21 years with known diabetic retinopathy (true positives) in the enriched cohort
- No time limit on last diabetic eye exam for the enriched cohort
You will not qualify if you...
- Known diabetic eye exam in the last 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Johns Hopkins Pediatric Diabetes Center
Baltimore, Maryland, United States, 21287
Actively Recruiting
Research Team
R
Risa M Wolf, MD
CONTACT
A
Alvin Liu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here